Cost-of-illness studies in the United States: a systematic review of methodologies used for direct cost
- PMID: 18237356
- DOI: 10.1111/j.1524-4733.2007.00210.x
Cost-of-illness studies in the United States: a systematic review of methodologies used for direct cost
Abstract
Objectives: We undertake a systematic review to examine the methods used by researchers in developing cost-of-illness (COI) studies. This review aims to categorize the approaches that the published literature uses in terms of perspective, scope, components of care analyzed in the literature, data sets, and valuation approaches used for direct cost. It draws conclusions regarding the adequacy of current COI research methods and makes recommendations on improving them.
Methods: The online bibliographic information service HealthSTAR (which incorporates MEDLINE) was used to search for COI studies in the research literature published during the period from 2000 to 2004. The search strategy used the term "cost of illness" as a MeSH (medical subject heading) term.
Results: The HealthSTAR literature search identified references to 650 articles. Review of abstracts resulted in the identification of 170 of these for a more detailed review. This process identified 52 articles that met all criteria of COI studies. We identified 218 components of care analyzed across the 52 articles. Private-insurance or employer-claims data sets comprised the largest source of utilization and cost information among the studies.
Conclusion: Analyzing cost of illness presents useful opportunities for communicating with the public and policymakers on the relative importance of specific diseases and injuries. Our research, however, indicates that COI studies employ varied approaches and many articles have methodological limitations. Without well-accepted standards to guide researchers in their execution of these studies, policymakers and the general public must be wary of the methods used in their calculation and subsequent results.
Similar articles
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
Cited by
-
Publication of Cost-of-Illness Studies: Does Methodological Complexity Matter?Pharmacoeconomics. 2016 Oct;34(10):1067-70. doi: 10.1007/s40273-016-0438-4. Pharmacoeconomics. 2016. PMID: 27503564 No abstract available.
-
Cost of illness in a super-aged society-comparison of breast, lung, and prostate cancer in Japan.BMC Geriatr. 2022 Dec 14;22(1):964. doi: 10.1186/s12877-022-03683-3. BMC Geriatr. 2022. PMID: 36517755 Free PMC article.
-
Complex home care: Part 2- family annual income, insurance premium, and out-of-pocket expenses.Nurs Econ. 2010 Sep-Oct;28(5):323-9. Nurs Econ. 2010. PMID: 21158253 Free PMC article.
-
National cost study versus hospital cost accounting for organ recovery cost assessment in a French hospital group.Cost Eff Resour Alloc. 2018 Oct 11;16:34. doi: 10.1186/s12962-018-0155-2. eCollection 2018. Cost Eff Resour Alloc. 2018. PMID: 30356786 Free PMC article.
-
Different levels of care for follow-up of adults with congenital heart disease: a cost analysis scrutinizing the impact on medical costs, hospitalizations, and emergency department visits.Eur J Health Econ. 2021 Aug;22(6):951-960. doi: 10.1007/s10198-021-01300-5. Epub 2021 Apr 9. Eur J Health Econ. 2021. PMID: 33835328
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous